Oxidative stress and heart failure - PubMed (original) (raw)
Affiliations
- PMID: 12722552
Review
Oxidative stress and heart failure
J A Byrne et al. Arch Mal Coeur Vaiss. 2003 Mar.
Abstract
Despite advances in treatment, chronic congestive heart failure carries a poor prognosis and remains a leading cause of cardiovascular death. Accumulating evidence suggests that reactive oxygen species (ROS) play an important role in the development and progression of heart failure, regardless of the etiology. Under pathophysiological conditions, ROS have the potential to cause cellular damage and dysfunction. Whether the effects are beneficial or harmful will depend upon site, source and amount of ROS produced, and the overall redox status of the cell. All cardiovascular cell types are capable of producing ROS, and the major enzymatic sources in heart failure are mitochondria, xanthine oxidases and the nonphagocytic NADPH oxidases (Noxs). As well as direct effects on cellular enzymatic and protein function, ROS have been implicated in the development of agonist-induced cardiac hypertrophy, cardiomyocyte apoptosis and remodelling of the failing myocardium. These alterations in phenotype are driven by redox-sensitive gene expression, and in this way ROS may act a potent intracellular second messengers. Recent experimental studies have suggested a possible causal role for increased ROS in the development of contractile dysfunction following myocardial infarction and pressure overload, however the precise contribution of different cellular and enzymatic sources involved remain under investigation.
Similar articles
- NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure.
Murdoch CE, Zhang M, Cave AC, Shah AM. Murdoch CE, et al. Cardiovasc Res. 2006 Jul 15;71(2):208-15. doi: 10.1016/j.cardiores.2006.03.016. Epub 2006 Mar 27. Cardiovasc Res. 2006. PMID: 16631149 Review. - Role of oxidative stress in cardiac remodelling after myocardial infarction.
Grieve DJ, Byrne JA, Cave AC, Shah AM. Grieve DJ, et al. Heart Lung Circ. 2004 Jun;13(2):132-8. doi: 10.1016/j.hlc.2004.02.008. Heart Lung Circ. 2004. PMID: 16352183 - Involvement of NADPH oxidases in cardiac remodelling and heart failure.
Sirker A, Zhang M, Murdoch C, Shah AM. Sirker A, et al. Am J Nephrol. 2007;27(6):649-60. doi: 10.1159/000109148. Epub 2007 Sep 27. Am J Nephrol. 2007. PMID: 17901689 Review. - Mitochondrial oxidative stress and dysfunction in myocardial remodelling.
Tsutsui H, Kinugawa S, Matsushima S. Tsutsui H, et al. Cardiovasc Res. 2009 Feb 15;81(3):449-56. doi: 10.1093/cvr/cvn280. Epub 2008 Oct 14. Cardiovasc Res. 2009. PMID: 18854381 Review. - NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.
Paravicini TM, Touyz RM. Paravicini TM, et al. Diabetes Care. 2008 Feb;31 Suppl 2:S170-80. doi: 10.2337/dc08-s247. Diabetes Care. 2008. PMID: 18227481 Review.
Cited by
- Thioredoxin and ventricular remodeling.
Ago T, Sadoshima J. Ago T, et al. J Mol Cell Cardiol. 2006 Nov;41(5):762-73. doi: 10.1016/j.yjmcc.2006.08.006. Epub 2006 Sep 26. J Mol Cell Cardiol. 2006. PMID: 17007870 Free PMC article. Review. - Inhibition of apoptosis-regulated signaling kinase-1 and prevention of congestive heart failure by estrogen.
Satoh M, Matter CM, Ogita H, Takeshita K, Wang CY, Dorn GW 2nd, Liao JK. Satoh M, et al. Circulation. 2007 Jun 26;115(25):3197-204. doi: 10.1161/CIRCULATIONAHA.106.657981. Epub 2007 Jun 11. Circulation. 2007. PMID: 17562954 Free PMC article. - Changes in oxidative balance in rat pericytes exposed to diabetic conditions.
Manea A, Constantinescu E, Popov D, Raicu M. Manea A, et al. J Cell Mol Med. 2004 Jan-Mar;8(1):117-26. doi: 10.1111/j.1582-4934.2004.tb00266.x. J Cell Mol Med. 2004. PMID: 15090267 Free PMC article. - miR-499 protects cardiomyocytes from H 2O 2-induced apoptosis via its effects on Pdcd4 and Pacs2.
Wang J, Jia Z, Zhang C, Sun M, Wang W, Chen P, Ma K, Zhang Y, Li X, Zhou C. Wang J, et al. RNA Biol. 2014;11(4):339-50. doi: 10.4161/rna.28300. Epub 2014 Feb 27. RNA Biol. 2014. PMID: 24646523 Free PMC article. - Long-term administration of tempol attenuates postinfarct ventricular dysfunction and sympathetic activity in rats.
Shi Z, Chen AD, Xu Y, Chen Q, Gao XY, Wang W, Zhu GQ. Shi Z, et al. Pflugers Arch. 2009 Jun;458(2):247-57. doi: 10.1007/s00424-008-0627-x. Epub 2009 Jan 9. Pflugers Arch. 2009. PMID: 19132383
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials